DOI:
10.1055/s-00000020
Geburtshilfe und Frauenheilkunde
LinksClose Window
References
Vahdat LT, Pruitt B, Fabian CJ et al.
Phase II study of eribulin mesylate, a halichondrin B analog, in patients with metastatic breast cancer previously treated with an anthracycline and a taxane.
J Clin Oncol 2009;
27: 2954-2961
We do not assume any responsibility for the contents of the web pages of other providers.